1. Home
  2. SCPH vs OTLY Comparison

SCPH vs OTLY Comparison

Compare SCPH & OTLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • OTLY
  • Stock Information
  • Founded
  • SCPH 2013
  • OTLY 1994
  • Country
  • SCPH United States
  • OTLY Sweden
  • Employees
  • SCPH N/A
  • OTLY N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • OTLY Packaged Foods
  • Sector
  • SCPH Health Care
  • OTLY Consumer Staples
  • Exchange
  • SCPH Nasdaq
  • OTLY Nasdaq
  • Market Cap
  • SCPH 299.0M
  • OTLY 303.5M
  • IPO Year
  • SCPH 2017
  • OTLY 2021
  • Fundamental
  • Price
  • SCPH $5.63
  • OTLY $17.95
  • Analyst Decision
  • SCPH Buy
  • OTLY Buy
  • Analyst Count
  • SCPH 3
  • OTLY 5
  • Target Price
  • SCPH $12.00
  • OTLY $19.25
  • AVG Volume (30 Days)
  • SCPH 2.3M
  • OTLY 163.4K
  • Earning Date
  • SCPH 11-12-2025
  • OTLY 11-06-2025
  • Dividend Yield
  • SCPH N/A
  • OTLY N/A
  • EPS Growth
  • SCPH N/A
  • OTLY N/A
  • EPS
  • SCPH N/A
  • OTLY N/A
  • Revenue
  • SCPH $49,969,000.00
  • OTLY $828,200,000.00
  • Revenue This Year
  • SCPH $108.95
  • OTLY $3.83
  • Revenue Next Year
  • SCPH $78.30
  • OTLY $4.51
  • P/E Ratio
  • SCPH N/A
  • OTLY N/A
  • Revenue Growth
  • SCPH 107.79
  • OTLY 4.43
  • 52 Week Low
  • SCPH $1.94
  • OTLY $6.00
  • 52 Week High
  • SCPH $6.28
  • OTLY $20.80
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.37
  • OTLY 58.03
  • Support Level
  • SCPH $4.33
  • OTLY $16.50
  • Resistance Level
  • SCPH $5.62
  • OTLY $17.75
  • Average True Range (ATR)
  • SCPH 0.05
  • OTLY 0.83
  • MACD
  • SCPH 0.01
  • OTLY -0.12
  • Stochastic Oscillator
  • SCPH 93.75
  • OTLY 65.64

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About OTLY Oatly Group AB

Oatly Group AB is engaged in the food and drinks industry. Some of its products include Oat Drink, Chilled Oat Drink, Oatgurt, Creamy Oat, and Icecreams, among others. It caters to Sweden, Germany, the United Kingdom, Netherlands, North America, Finland, and Other markets. The company generates revenue from the EMEA, Americas, and Asia regions, with the majority of revenue generated from the EMEA region.

Share on Social Networks: